The latest from the Proscia blog: Everyone’s talking about AI in therapeutic R&D, but it’s not always easy to cut through the hype to understand where it’s making a real impact today. One of the clearest signals of progress?...

From the Proscia blog: As more laboratories transition from glass slides to images, one sometimes underestimated success factor is laboratory information system (LIS) integration. The LIS continues to underpin the diagnostic workflow, from...

The latest from the Proscia blog. Tom Gallo is Proscia’s Chief Financial Officer. Arun Ananth is the company’s Chief Commercial Officer.  For years, AI-driven pathology has promised to deliver top- and bottom-line impact for diagnostic...

Amid momentum, the company generates millions in new high-margin revenue for diagnostic network Introduces AI application suites to demonstrate the future of pathology for high-impact use cases Launches 24/7 support to meet...

From the Proscia blog: With AI-driven pathology rapidly advancing, we launched The 2025 Laboratory Leadership Report to better understand what’s top of mind for today’s pathology leaders—and where they’re headed next. Some findings...

The latest from the Proscia blog: By Coleman Stavish | June 25, 2025 The Spring 2025 DICOM Working Group 26 (WG26) Whole Slide Imaging (WSI) Connectathon brought together key stakeholders shaping the future of digital pathology...